Skip to main content
Top
Published in: Inflammation 1/2014

01-02-2014

Hyperleptinemia: Implications on the Inflammatory State and Vascular Protection in Obese Adolescents Submitted to an Interdisciplinary Therapy

Authors: Priscila L. Sanches, Marco T. de Mello, Natália Elias, Francisco A. H. Fonseca, Raquel M. S. Campos, June Carnier, Aline de Piano, Deborah C. L. Masquio, Patrícia L. Silva, Lila M. Oyama, Flavia C. Corgosinho, Cláudia M. O. Nascimento, Lian Tock, Carolina Ackel D’Elia, Sergio Tufik, Ana R. Dâmaso

Published in: Inflammation | Issue 1/2014

Login to get access

Abstract

The low-grade systemic inflammation seen in obesity may affect the actions of some adipose tissue-derived adipokines that are involved in the regulation of vascular function. We sought to verify whether hyperleptinemia may influence the inflammatory and atherogenic responses in obese adolescents undergoing interdisciplinary therapy. Thirty-four obese adolescents underwent interdisciplinary therapy for 1 year. Subjects were considered hyperleptinemic if they had baseline values of leptin above 20 ng/mL for boys and 24 ng/mL for girls. Both groups showed an improvement in body composition and a reduction in carotid intima-media thickness. However, only subjects in the non-hyperleptinemic group showed an increase in adiponectin concentration after therapy. Moreover, leptin concentration was positively correlated with adiponectin and inversely correlated with PAI-1 in this group. Hyperleptinemic state may impair the attenuation of inflammation in obese adolescents undergoing interdisciplinary therapy, particularly by impeding the increase in adiponectin concentration, which is directly involved in vascular protection.
Literature
1.
go back to reference Zhang, H., J. Cui, and C. Zhang. 2010. Emerging role of adipokines as mediators in atherosclerosis. World Journal of Cardiology 2(11): 370–376.CrossRef Zhang, H., J. Cui, and C. Zhang. 2010. Emerging role of adipokines as mediators in atherosclerosis. World Journal of Cardiology 2(11): 370–376.CrossRef
2.
go back to reference Bełtowski, J. 2012. Leptin and the regulation of endothelial function in physiological and pathological conditions. Clinical and Experimental Pharmacology and Physiology 39(2): 168–178.CrossRef Bełtowski, J. 2012. Leptin and the regulation of endothelial function in physiological and pathological conditions. Clinical and Experimental Pharmacology and Physiology 39(2): 168–178.CrossRef
3.
go back to reference Mantzoros, C.S., F. Magkos, M. Brinkoetter, E. Sienkiewicz, T.A. Dardeno, S.Y. Kim, O.P. Hamnvik, and A. Koniaris. 2011. Leptin in human physiology and pathophysiology. American Journal of Physiology, Endocrinology and Metabolism 301(4): E567–E584.CrossRef Mantzoros, C.S., F. Magkos, M. Brinkoetter, E. Sienkiewicz, T.A. Dardeno, S.Y. Kim, O.P. Hamnvik, and A. Koniaris. 2011. Leptin in human physiology and pathophysiology. American Journal of Physiology, Endocrinology and Metabolism 301(4): E567–E584.CrossRef
4.
go back to reference Martin, S.S., A. Qasim, and M.P. Reilly. 2008. Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease. Journal of the American College of Cardiology 52(15): 1201–1210.CrossRef Martin, S.S., A. Qasim, and M.P. Reilly. 2008. Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease. Journal of the American College of Cardiology 52(15): 1201–1210.CrossRef
5.
go back to reference Dâmaso, A.R., A. de Piano, P.L. Sanches, F. Corgosinho, L. Tock, L.M. Oyama, L. Tock, C.M. do Nascimento, S. Tufik, and M.T. de Mello. 2011. Hyperleptinemia in obese adolescents deregulates neuropeptides during weight loss. Peptides 32(7): 1384–1391.CrossRef Dâmaso, A.R., A. de Piano, P.L. Sanches, F. Corgosinho, L. Tock, L.M. Oyama, L. Tock, C.M. do Nascimento, S. Tufik, and M.T. de Mello. 2011. Hyperleptinemia in obese adolescents deregulates neuropeptides during weight loss. Peptides 32(7): 1384–1391.CrossRef
6.
go back to reference González, M., Bibiloni M. Del Mar, A. Pons, I. Llompart, and J.A. Tur. 2012. Inflammatory markers and metabolic syndrome among adolescents. European Journal of Clinical Nutrition 66(10): 1141–1145.CrossRef González, M., Bibiloni M. Del Mar, A. Pons, I. Llompart, and J.A. Tur. 2012. Inflammatory markers and metabolic syndrome among adolescents. European Journal of Clinical Nutrition 66(10): 1141–1145.CrossRef
7.
go back to reference Matsuzawa, Y. 2005. Adiponectin: identification, physiology and clinical relevance in metabolic and vascular disease. Atherosclerosis Supplements 6(2): 7–14.CrossRef Matsuzawa, Y. 2005. Adiponectin: identification, physiology and clinical relevance in metabolic and vascular disease. Atherosclerosis Supplements 6(2): 7–14.CrossRef
8.
go back to reference Beauloye, V., F. Zech, H.T. Tran, P. Clapuyt, M. Maes, and S.M. Brichard. 2007. Determinants of early atherosclerosis in obese children and adolescents. Journal of Clinical Endocrinology and Metabolism 92: 3025–3032.CrossRef Beauloye, V., F. Zech, H.T. Tran, P. Clapuyt, M. Maes, and S.M. Brichard. 2007. Determinants of early atherosclerosis in obese children and adolescents. Journal of Clinical Endocrinology and Metabolism 92: 3025–3032.CrossRef
9.
go back to reference Corgosinho, F.C., A. de Piano, P.L. Sanches, R.M. Campos, P.L. Silva, J. Carnier, L.M. Oyama, L. Tock, S. Tufik, M.T. de Mello, and A.R. Dâmaso. 2012. The role of PAI-1 and adiponectin on the inflammatory state and energy balance in obese adolescents with metabolic syndrome. Inflammation 35(3): 944–951.CrossRef Corgosinho, F.C., A. de Piano, P.L. Sanches, R.M. Campos, P.L. Silva, J. Carnier, L.M. Oyama, L. Tock, S. Tufik, M.T. de Mello, and A.R. Dâmaso. 2012. The role of PAI-1 and adiponectin on the inflammatory state and energy balance in obese adolescents with metabolic syndrome. Inflammation 35(3): 944–951.CrossRef
10.
go back to reference de Lima, Sanches P., M.T. de Mello, N. Elias, F.A. Fonseca, A. de Piano, J. Carnier, L.M. Oyama, L. Tock, S. Tufik, and A.R. Dâmaso. 2011. Improvement in HOMA-IR is an independent predictor of reduced carotid intima-media thickness in obese adolescents participating in an interdisciplinary weight-loss program. Hypertension Research 34(2): 232–238.CrossRef de Lima, Sanches P., M.T. de Mello, N. Elias, F.A. Fonseca, A. de Piano, J. Carnier, L.M. Oyama, L. Tock, S. Tufik, and A.R. Dâmaso. 2011. Improvement in HOMA-IR is an independent predictor of reduced carotid intima-media thickness in obese adolescents participating in an interdisciplinary weight-loss program. Hypertension Research 34(2): 232–238.CrossRef
11.
go back to reference Korda, M., R. Kubant, S. Patton, and T. Malinski. 2008. Leptin-induced endothelial dysfunction in obesity. American Journal of Physiology-Heart and Circulatory Physiology 295(4): 1514–1521.CrossRef Korda, M., R. Kubant, S. Patton, and T. Malinski. 2008. Leptin-induced endothelial dysfunction in obesity. American Journal of Physiology-Heart and Circulatory Physiology 295(4): 1514–1521.CrossRef
12.
go back to reference Brennan, A.M., T.Y. Li, I. Kelesidis, A. Gavrila, F.B. Hu, and C.S. Mantzoros. 2007. Circulating leptin levels are not associated with cardiovascular morbidity and mortality in women with diabetes: a prospective cohort study. Diabetologia 50: 1178–1185.CrossRef Brennan, A.M., T.Y. Li, I. Kelesidis, A. Gavrila, F.B. Hu, and C.S. Mantzoros. 2007. Circulating leptin levels are not associated with cardiovascular morbidity and mortality in women with diabetes: a prospective cohort study. Diabetologia 50: 1178–1185.CrossRef
13.
go back to reference Matarese, G., C. Mantzoros, and A. La Cava. 2007. Leptin and adipocytokines: bridging the gap between immunity and atherosclerosis. Current Pharmaceutical Design 13: 3676–3680.CrossRef Matarese, G., C. Mantzoros, and A. La Cava. 2007. Leptin and adipocytokines: bridging the gap between immunity and atherosclerosis. Current Pharmaceutical Design 13: 3676–3680.CrossRef
14.
go back to reference Tanner, J.M., and R.H. Whitehouse. 1976. Clinical longitudinal standards for height, weight, weight velocity and stages of puberty. Archives of Disease in Childhood 51: 170–179.CrossRef Tanner, J.M., and R.H. Whitehouse. 1976. Clinical longitudinal standards for height, weight, weight velocity and stages of puberty. Archives of Disease in Childhood 51: 170–179.CrossRef
16.
go back to reference Gutin, B., L. Ramsey, P. Barbeau, W. Cannady, M. Ferguson, M. Litaker, and S. Owens. 1999. Plasma leptin concentrations in obese children: changes during 4-mo periods with and without physical training. American Journal of Clinical Nutrition 69: 388–394.CrossRef Gutin, B., L. Ramsey, P. Barbeau, W. Cannady, M. Ferguson, M. Litaker, and S. Owens. 1999. Plasma leptin concentrations in obese children: changes during 4-mo periods with and without physical training. American Journal of Clinical Nutrition 69: 388–394.CrossRef
17.
go back to reference de Piano, A., W.L. Prado, D.A. Caranti, K.O. Siqueira, S.G. Stella, M. Lofrano, L. Tock, D.M. Cristofalo, H. Lederman, S. Tufik, M.T. de Mello, and A.R. Dâmaso. 2007. Metabolic and nutritional profile of obese adolescents with nonalcoholic fatty liver disease. Journal of Pediatric Gastroenterology and Nutrition 44: 446–452.CrossRef de Piano, A., W.L. Prado, D.A. Caranti, K.O. Siqueira, S.G. Stella, M. Lofrano, L. Tock, D.M. Cristofalo, H. Lederman, S. Tufik, M.T. de Mello, and A.R. Dâmaso. 2007. Metabolic and nutritional profile of obese adolescents with nonalcoholic fatty liver disease. Journal of Pediatric Gastroenterology and Nutrition 44: 446–452.CrossRef
18.
go back to reference Guardamagna, O., F. Abello, P. Saracco, V. Baracco, E. Rolfo, and M. Pirro. 2009. Endothelial activation, inflammation and premature atherosclerosis in children with familial dyslipidemia. Atherosclerosis 207: 471–475.CrossRef Guardamagna, O., F. Abello, P. Saracco, V. Baracco, E. Rolfo, and M. Pirro. 2009. Endothelial activation, inflammation and premature atherosclerosis in children with familial dyslipidemia. Atherosclerosis 207: 471–475.CrossRef
19.
go back to reference Rabago Rodriguez, R., R.A. Gómez-Díaz, J. Tanus Haj, F.J. Avelar Garnica, E. Ramirez Soriano, E. Nishimura Meguro, C.A. Aguilar-Salinas, and N.H. Wacher. 2007. Carotid intima-media thickness in pediatric type 1 diabetic patients. Diabetes Care 30: 2599–2602.CrossRef Rabago Rodriguez, R., R.A. Gómez-Díaz, J. Tanus Haj, F.J. Avelar Garnica, E. Ramirez Soriano, E. Nishimura Meguro, C.A. Aguilar-Salinas, and N.H. Wacher. 2007. Carotid intima-media thickness in pediatric type 1 diabetic patients. Diabetes Care 30: 2599–2602.CrossRef
20.
go back to reference Friedewald, W., R. Levy, and D. Friderickson. 1972. Estimation of the concentration of low density protein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry 18: 449–515.CrossRef Friedewald, W., R. Levy, and D. Friderickson. 1972. Estimation of the concentration of low density protein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry 18: 449–515.CrossRef
21.
go back to reference Quijada, Z., M. Paoli, Y. Zerpa, N. Camacho, R. Cichetti, V. Villarroel, G. Arata-Bellabarba, and R. Lanes. 2008. The triglyceride/HDL-cholesterol ratio as a marker of cardiovascular risk in obese children; association with traditional and emergent risk factors. Pediatric Diabetes 9: 464–471.CrossRef Quijada, Z., M. Paoli, Y. Zerpa, N. Camacho, R. Cichetti, V. Villarroel, G. Arata-Bellabarba, and R. Lanes. 2008. The triglyceride/HDL-cholesterol ratio as a marker of cardiovascular risk in obese children; association with traditional and emergent risk factors. Pediatric Diabetes 9: 464–471.CrossRef
22.
go back to reference Matsuhisa, M., Y. Yamasaki, M. Emoto, M. Shimabukuro, T. Funahashi, and Y. Matsuzawa. 2007. A novel index of insulin resistance determined from the homeostasis model assessment index and adiponectin levels in Japanese subjects. Diabetes Research and Clinical Practice 77: 151–154.CrossRef Matsuhisa, M., Y. Yamasaki, M. Emoto, M. Shimabukuro, T. Funahashi, and Y. Matsuzawa. 2007. A novel index of insulin resistance determined from the homeostasis model assessment index and adiponectin levels in Japanese subjects. Diabetes Research and Clinical Practice 77: 151–154.CrossRef
23.
go back to reference Chobanian, A.V., G.L. Bakris, H.R. Black, W.C. Cushman, L.A. Green, J.L. Izzo Jr., D.W. Jones, B.J. Materson, S. Oparil, J.T. Wright Jr., E.J. Roccella, and National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. 2003. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. Journal of the American Medical Association 289(19): 2560–2572.CrossRef Chobanian, A.V., G.L. Bakris, H.R. Black, W.C. Cushman, L.A. Green, J.L. Izzo Jr., D.W. Jones, B.J. Materson, S. Oparil, J.T. Wright Jr., E.J. Roccella, and National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. 2003. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. Journal of the American Medical Association 289(19): 2560–2572.CrossRef
24.
go back to reference Giuliano, I.C.B., B. Caramelli, L. Pellanda, B. Duncan, S. Mattos, and F.A.H. Fonseca. 2006. I Guideline for preventing atherosclerosis in childhood and adolescence. International Atherosclerosis 1: 1–30.. Giuliano, I.C.B., B. Caramelli, L. Pellanda, B. Duncan, S. Mattos, and F.A.H. Fonseca. 2006. I Guideline for preventing atherosclerosis in childhood and adolescence. International Atherosclerosis 1: 1–30..
25.
go back to reference NRC. 2001. Dietary reference intake: applications in dietary assessment. Washington, DC: National Academic Press. NRC. 2001. Dietary reference intake: applications in dietary assessment. Washington, DC: National Academic Press.
26.
go back to reference Donnelly, J.E., S.N. Blair, J.M. Jakicic, M.M. Manore, J.W. Rankin, and B.K. Smith. 2009. Appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults. Medicine & Science in Sports & Exercise 41: 459–471.CrossRef Donnelly, J.E., S.N. Blair, J.M. Jakicic, M.M. Manore, J.W. Rankin, and B.K. Smith. 2009. Appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults. Medicine & Science in Sports & Exercise 41: 459–471.CrossRef
27.
go back to reference Kelishadi, R., M. Hashemi, N. Mohammadifard, S. Asgary, and N. Khavarian. 2008. Association of changes in oxidative and proinflammatory states with changes in vascular function after a lifestyle modification trial among obese children. Clinical Chemistry 54(1): 147–153.CrossRef Kelishadi, R., M. Hashemi, N. Mohammadifard, S. Asgary, and N. Khavarian. 2008. Association of changes in oxidative and proinflammatory states with changes in vascular function after a lifestyle modification trial among obese children. Clinical Chemistry 54(1): 147–153.CrossRef
28.
go back to reference Monzavi, R., D. Dreimane, M.E. Geffner, S. Braun, B. Conrad, M. Klier, and F.R. Kaufman. 2006. Improvement in risk factors for metabolic syndrome and insulin resistance in overweight youth who are treated with lifestyle intervention. Pediatrics 117: e1111–e1118.CrossRef Monzavi, R., D. Dreimane, M.E. Geffner, S. Braun, B. Conrad, M. Klier, and F.R. Kaufman. 2006. Improvement in risk factors for metabolic syndrome and insulin resistance in overweight youth who are treated with lifestyle intervention. Pediatrics 117: e1111–e1118.CrossRef
29.
go back to reference Matarese, G., S. Moschos, and C.H. Mantzoros. 2005. Leptin in immunology. Journal of Immunology 173: 3137–3142..CrossRef Matarese, G., S. Moschos, and C.H. Mantzoros. 2005. Leptin in immunology. Journal of Immunology 173: 3137–3142..CrossRef
30.
go back to reference Zhao, Y., R. Sun, L. You, C. Gao, and Z. Tian. 2003. Expression of leptin receptor and response to leptin stimulation of human natural killer cell lines. Biochemical and Biophysical Research Communications 300(2): 247–252.CrossRef Zhao, Y., R. Sun, L. You, C. Gao, and Z. Tian. 2003. Expression of leptin receptor and response to leptin stimulation of human natural killer cell lines. Biochemical and Biophysical Research Communications 300(2): 247–252.CrossRef
31.
go back to reference Li, F.Y., K.K. Cheng, K.S. Lam, P.M. Vanhoutte, and A. Xu. 2011. Cross-talk between adipose tissue and vasculature: role of adiponectin. Acta Physiologica (Oxford, England) 203(1): 167–180.CrossRef Li, F.Y., K.K. Cheng, K.S. Lam, P.M. Vanhoutte, and A. Xu. 2011. Cross-talk between adipose tissue and vasculature: role of adiponectin. Acta Physiologica (Oxford, England) 203(1): 167–180.CrossRef
32.
go back to reference Ohashi, K., N. Ouchi, and Y. Matsuzawa. 2012. Anti-inflammatory and anti-atherogenic properties of adiponectin. Biochimie 94(10): 2137–2142.CrossRef Ohashi, K., N. Ouchi, and Y. Matsuzawa. 2012. Anti-inflammatory and anti-atherogenic properties of adiponectin. Biochimie 94(10): 2137–2142.CrossRef
33.
go back to reference Ouchi, N., and K. Walsh. 2007. Adiponectin as an anti-inflammatory factor. Clinica Chimica Acta 380(1–2): 24–30.CrossRef Ouchi, N., and K. Walsh. 2007. Adiponectin as an anti-inflammatory factor. Clinica Chimica Acta 380(1–2): 24–30.CrossRef
34.
go back to reference Norata, G.D., S. Raselli, L. Grigore, K. Garlaschelli, E. Dozio, P. Magni, and A.L. Catapano. 2007. Leptin: adiponectin ratio is an independent predictor of intima media thickness of the common carotid artery. Stroke 38: 2844–2846.CrossRef Norata, G.D., S. Raselli, L. Grigore, K. Garlaschelli, E. Dozio, P. Magni, and A.L. Catapano. 2007. Leptin: adiponectin ratio is an independent predictor of intima media thickness of the common carotid artery. Stroke 38: 2844–2846.CrossRef
35.
go back to reference Makni, E., W. Moalla, G. Lac, C. Aouichaoui, D. Cannon, M. Elloumi, and Z. Tabka. 2012. The Homeostasis Model Assessment-adiponectin (HOMA-AD) is the most sensitive predictor of insulin resistance in obese children. Annales d’endocrinologie 73(1): 26–33..CrossRef Makni, E., W. Moalla, G. Lac, C. Aouichaoui, D. Cannon, M. Elloumi, and Z. Tabka. 2012. The Homeostasis Model Assessment-adiponectin (HOMA-AD) is the most sensitive predictor of insulin resistance in obese children. Annales d’endocrinologie 73(1): 26–33..CrossRef
36.
go back to reference Dullaart, R.P., R. de Vries, A. Van Tol, and W.J. Sluiter. 2007. Lower plasma adiponectin is a marker of increased intima-media thickness associated with type 2 diabetes mellitus and with male gender. European Journal of Endocrinology 156: 387–394.CrossRef Dullaart, R.P., R. de Vries, A. Van Tol, and W.J. Sluiter. 2007. Lower plasma adiponectin is a marker of increased intima-media thickness associated with type 2 diabetes mellitus and with male gender. European Journal of Endocrinology 156: 387–394.CrossRef
37.
go back to reference Singh, P., T.E. Peterson, K.R. Barber, F.S. Kuniyoshi, A. Jensen, M. Hoffmann, A.S. Shamsuzzaman, and V.K. Somers. 2010. Leptin upregulates the expression of plasminogen activator inhibitor-1 in human vascular endothelial cells. Biochemical and Biophysical Research Communications 392(1): 47–52.CrossRef Singh, P., T.E. Peterson, K.R. Barber, F.S. Kuniyoshi, A. Jensen, M. Hoffmann, A.S. Shamsuzzaman, and V.K. Somers. 2010. Leptin upregulates the expression of plasminogen activator inhibitor-1 in human vascular endothelial cells. Biochemical and Biophysical Research Communications 392(1): 47–52.CrossRef
38.
go back to reference Lijnen, H.R. 2005. Pleiotropic functions of plasminogen activator inhibitor-1. Journal of Thrombosis and Haemostasis 3(1): 35–45.CrossRef Lijnen, H.R. 2005. Pleiotropic functions of plasminogen activator inhibitor-1. Journal of Thrombosis and Haemostasis 3(1): 35–45.CrossRef
39.
go back to reference Scotece, M., J. Conde, R. Gómez, V. López, J. Pino, A. González, F. Lago, J.J. Gómez-Reino, and O. Gualillo. 2012. Role of adipokines in atherosclerosis: interferences with cardiovascular complications in rheumatic diseases. Mediators of Inflammation 125458. Scotece, M., J. Conde, R. Gómez, V. López, J. Pino, A. González, F. Lago, J.J. Gómez-Reino, and O. Gualillo. 2012. Role of adipokines in atherosclerosis: interferences with cardiovascular complications in rheumatic diseases. Mediators of Inflammation 125458.
Metadata
Title
Hyperleptinemia: Implications on the Inflammatory State and Vascular Protection in Obese Adolescents Submitted to an Interdisciplinary Therapy
Authors
Priscila L. Sanches
Marco T. de Mello
Natália Elias
Francisco A. H. Fonseca
Raquel M. S. Campos
June Carnier
Aline de Piano
Deborah C. L. Masquio
Patrícia L. Silva
Lila M. Oyama
Flavia C. Corgosinho
Cláudia M. O. Nascimento
Lian Tock
Carolina Ackel D’Elia
Sergio Tufik
Ana R. Dâmaso
Publication date
01-02-2014
Publisher
Springer US
Published in
Inflammation / Issue 1/2014
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-013-9709-9

Other articles of this Issue 1/2014

Inflammation 1/2014 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.